See Where We’ve Been—and Where We’re Going.

First Commercial Implantation and Publication of 12-month Clinical Study Data for Glyder® Facet Restoration Device

20 Nov 2014 - Zyga Technology, Inc., a medical device company focused on the design, development and commercialization of minimally invasive products to treat underserved conditions of the lumbar spine, today announced announced completion of the first Glyder® Facet Restoration Device commercial surgery. The Company also announced the publication of 12-month primary outcome data from the GLISSADE study: a prospective, 40-patient trial that studied the Glyder® Facet Restoration System in the treatment of chronic facetogenic pain. The data were published online in Annals of Surgical Innovation and Research.

Read More

11 Nov 2014 -
First Patient Enrolled in Glyder® Facet Restoration Clinical Study (PDF)

11 Nov 2014
Zyga is hiring! Product Marketing Associate (PDF)

27 Oct 2014
Zyga Technology announces CE Mark Approval for Glyder® Facet restoration (PDF)

25 Sep 2014
Zyga Technology announces $10 Million financing completed (PDF)

29 May 2014
Zyga announces first patient enrollment in the SAIF study (PDF)

31 Jan 2013
Zyga completes enrollment in GLISSADE Clinical Study (PDF)

06 Jul 2012
Zyga featured in Minneapolis/St. Paul Business Journal (PDF)

16 May 2012
Zyga Technology, Inc. Announces $25 Million Venture Financing (PDF)

16 Jan 2012
Zyga Technology, Inc. Announces the Appointment of Jim Bullock as President and CEO (PDF)

24 Aug 2011
Zyga Technology, Inc. Announces Start of European Enrollment for the Glyder® Facet Resurfacing System Clinical Study (PDF)

18 Aug 2011
FDA Approves Updated Indications for Use for the SImmetry Sacroiliac Joint Fusion System (PDF)

18 Jan 2011
Zyga Technology, Inc. Receives FDA 510(K) Clearance for SImmetry Sacroiliac Joint Fusion System (PDF)

Media inquires:

Paul Hess
Business Unit Manager
952.698.9955
phess@zyga.com